Singapore markets open in 8 hours 25 minutes

NeuBase Therapeutics Inc (O7P.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.35100.0000 (0.00%)
At close: 08:27AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-30,417
-33,776
-25,409
-17,385
-26,132
Depreciation & amortisation
1,400
1,263
575.521
280.463
128.372
Stock-based compensation
1,595
2,898
3,696
5,195
8,959
Change in working capital
-1,976
177.067
361.159
479.303
622.784
Accounts payable
-781.566
35.142
294.548
-129.088
962.434
Other working capital
-29,829
-29,484
-20,312
-11,427
-3,398
Other non-cash items
-2,173
-
2,888
-
13,084
Net cash provided by operating activities
-29,431
-29,012
-18,874
-10,710
-2,845
Cash flows from investing activities
Investments in property, plant and equipment
-397.679
-471.711
-1,438
-716.82
-552.663
Acquisitions, net
-
0
-1,100
0
-884.981
Purchases of investments
0
-14,987
-59,989
0
-
Sales/maturities of investments
0
14,987
59,963
0
-
Net cash used for investing activities
-397.679
-471.741
-2,563
-716.82
-685.225
Cash flows from financing activities
Debt repayment
-181.548
-109.5
-8.77
0
-
Common stock issued
-
0
42,616
33,284
13,227
Common stock repurchased
-
-
-
0
-0.014
Other financing activities
-
-148.385
-381.797
-349.792
-90.081
Net cash used provided by (used for) financing activities
-110.687
-257.017
42,338
33,105
13,595
Net change in cash
-29,940
-29,741
20,901
21,678
10,064
Cash at beginning of period
47,326
52,893
31,992
10,314
249.6
Cash at end of period
17,386
23,153
52,893
31,992
10,314
Free cash flow
Operating cash flow
-29,431
-29,012
-18,874
-10,710
-2,845
Capital expenditure
-397.679
-471.711
-1,438
-716.82
-552.663
Free cash flow
-29,829
-29,484
-20,312
-11,427
-3,398